We examined the effects of WT-GSK-3β and pLXSN on the sensitivity of MCF-7 breast cancer cells to the chemotherapeutic drug docetaxel, and the GSK-3 inhibitors CHIR99021, SB415286, and tideglusib (Figure 17 and Table 2). Here, GSK3B is linked to breast carcinoma.